Michael Cima

Director at GelMEDIX.

Raised on GelMEDIX filings

$747K

of $2.5M offered across 1 Form D filing

Form D filings: 1
Teammates: 4
Last filing: Apr 30, 2026

Company

Biotech · Cambridge, MA

Hydrogel-delivered cell therapy for geographic atrophy

Hydrogel-delivered cell therapy for geographic atrophy

Investors: 5
Still open: $1.8M

Investors: 5
Sector: Biotech
HQ: Cambridge, MA

GelMEDIX filings

GelMEDIX Form D filings
Filed	Security	Sold of offered	Filing
Apr 30, 2026	Equity	$747K/ $2.5M	Form D/A

EquityFiled Apr 30, 2026Form D/A
$747K/ $2.5M

Works with

Also named on GelMEDIX filings

Max CotlerPresident and CEO, Form D signerForm D signer Parinaz MotamedyDirector Nasim AnnabiDirector Reza DanaDirector